Your best medicine news resource
Nov 3rd 2008Drug InformationBio-terrorism
BioDefense Corporation, producers of the new MAIL DEFENDER complete mailroom security solution, is on the front lines of combating bio-chemical assaults. “Incoming mail containing white powder discovered on October 30, 2008 at the Boston Herald, Christian Science Monitor and more than 100 media offices across the country are not ‘hoaxes.
More: continued here
Nov 2nd 2008Drug InformationBio-terrorism
Researchers at the University of Pittsburgh School of Medicine have been awarded $2.7 million from the Biomedical Advanced Research and Development Authority (BARDA), Department of Health and Human Services (HHS), to develop a radiation mitigator drug that could counter the effects of radiation exposure in case of large-scale public exposure.
More: continued here
Oct 29th 2008Drug InformationBio-terrorism
Medarex, Inc. (Nasdaq: MEDX), a leading monoclonal antibody company, and PharmAthene, Inc. (NYSE: PIP), a biodefense company developing medical countermeasures against biological and chemical threats, announced results from a pilot study showing that the anthrax anti-toxin, Valortim(R) (MDX-1303), enhanced survival as compared to a control group in a therapeutic animal model known as the New Zealand White (NZW) rabbit model.
More: continued here
Your best medicine news resource
